Insider · CIK 0001425738
Redmile Group, LLC
owner
Files at ADCT (ADC Therapeutics SA). First filing Dec 6, 2024, latest Dec 13, 2024.
Track record
Not enough history
Fewer than three past buys with six months of prices.
Median 6-month excess
-
after past buys, n = 0
Hit rate
-
past buys that beat the index over 6 months
Open-market trades
1 / 1
$609k bought, $52k sold
Signals
This insider’s open-market buys and sells, scored.
| Score | Side | Company | Value | Shares | Holdings change | Price context | Filed |
|---|---|---|---|---|---|---|---|
| 27Weak | buy | ADCT ADC Therapeutics SA | $609k | 200,000 | +1% | - | |
| 19Weak | sell | ADCT ADC Therapeutics SA | $52k | 25,352 | -0% | - |
Transactions
Every row this insider has filed, newest first.
| Date | Company | Transaction | Shares | Price | Value | Holdings after | Filed |
|---|---|---|---|---|---|---|---|
| Dec 11, 2024 | ADCT ADC Therapeutics SA | POpen-market purchase Common Shares, par value CHF 0.08 per shareindirect: See Footnotes | +50,000 | $2.28 | $114k | 15,616,731 | Dec 13, 2024 |
| Dec 11, 2024 | ADCT ADC Therapeutics SA | POpen-market purchase Common Shares, par value CHF 0.08 per shareindirect: See Footnotes | +50,000 | $3.81 | $191k | 15,666,731 | Dec 13, 2024 |
| Dec 11, 2024 | ADCT ADC Therapeutics SA | POpen-market purchase Common Shares, par value CHF 0.08 per share | +50,000 | $2.28 | $114k | 13,095,712 | Dec 13, 2024 |
| Dec 11, 2024 | ADCT ADC Therapeutics SA | POpen-market purchase Common Shares, par value CHF 0.08 per share | +50,000 | $3.81 | $191k | 13,145,712 | Dec 13, 2024 |
| Dec 4, 2024 | ADCT ADC Therapeutics SA | SOpen-market sale Common Shares, par value CHF 0.08 per shareindirect: See Footnotes | -25,352 | $2.07 | $52k | 15,566,731 | Dec 6, 2024 |
| Dec 4, 2024 | ADCT ADC Therapeutics SA | JOther Common Shares, par value CHF 0.08 per shareindirect: See Footnotes | -50,672 | $2.07 | $105k | 15,516,059 | Dec 6, 2024 |
| Dec 4, 2024 | ADCT ADC Therapeutics SA | JOther Common Shares, par value CHF 0.08 per shareindirect: See Footnotes | +50,672 | $2.07 | $105k | 15,566,731 | Dec 6, 2024 |
| Dec 4, 2024 | ADCT ADC Therapeutics SA | JOther Common Shares, par value CHF 0.08 per share | +50,672 | $2.07 | $105k | 13,045,712 | Dec 6, 2024 |
| Dec 4, 2024 | ADCT ADC Therapeutics SA | JOther Pre-Funded Warrantsderivativeindirect: See Footnotes | -26,656 | $2.07 | $55k | 8,136,609 | Dec 6, 2024 |
| Dec 4, 2024 | ADCT ADC Therapeutics SA | JOther Pre-Funded Warrantsderivativeindirect: See Footnotes | +26,656 | $2.07 | $55k | 8,163,265 | Dec 6, 2024 |
| Dec 4, 2024 | ADCT ADC Therapeutics SA | JOther Pre-Funded Warrantsderivative | +26,656 | $2.07 | $55k | 6,133,837 | Dec 6, 2024 |
Not investment advice. Scores and forward returns are decision support built from public SEC filings and past prices; they describe what happened after comparable filings, not what will happen after this one. Do your own research and size your risk.